LeMaitre Q1 2026 Financial Results
LeMaitre Vascular reported Q1 2026 sales of $66.6 million, up 11% year-over-year with 10% organic growth, while EPS surged 42% to $0.68 on strong operating leverage. Gross margin expanded 350 basis points to 72.7%, driving a 41% increase in operating income to $17.8 million and boosting cash position to $367.2 million.
Key figures
- Eps
- 0.68
- Guidance
- FY26 revenue $277mm-$283mm (Mid $280mm, +12%, +12% org.), EPS $2.93-$3.08 (Mid $3.00, +19%, +26% adj.)
- Revenue Yoy
- 11%
- Gross margin
- 72.7%
- Organic growth
- 10%
- Operating income
- 17775000
- Operating margin
- 27%
- Cash and marketable securities
- 367200000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.